Literature DB >> 16633303

[The solitary rectal ulcer syndrome].

Guillaume Meurette1, Nicolas Regenet, Eric Frampas, Christine Sagan, Joël Le Borgne, Paul-Antoine Lehur.   

Abstract

The solitary rectal ulcer syndrome is a rare debilitating disorder of the rectum characterized by perianal chronic pain with passage of blood and mucus. The pathogenesis remains uncertain, rectal prolapse and trauma from straining are the main hypothesis. The diagnosis includes clinical symptoms associated with endoscopic lesion (erythema, ulcer or polypoïd lesion) and histological features. Mano-metric studies and defecography are helpful to determinate an underlying defecation disorder or rectal prolapse. The treatment is controversial including a conservative option (medications and behavioural therapy) with poor long term results, and the surgical option (treatment of a rectal prolapse with or without resection of the lesion), more aggressive with uncertain results in a long follow-up period.

Entities:  

Mesh:

Year:  2006        PMID: 16633303     DOI: 10.1016/s0399-8320(06)73192-x

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  3 in total

1.  A systematic literature review on solitary rectal ulcer syndrome: is there a therapeutic consensus in 2018?

Authors:  Claire Gouriou; Marion Chambaz; Alain Ropert; Guillaume Bouguen; Véronique Desfourneaux; Laurent Siproudhis; Charlène Brochard
Journal:  Int J Colorectal Dis       Date:  2018-09-11       Impact factor: 2.571

2.  Biofeedback efficacy to improve clinical symptoms and endoscopic signs of solitary rectal ulcer syndrome.

Authors:  Mojgan Forootan; Masood Shekarchizadeh; Hamedreza Farmanara; Ahmad Reza Shekarchizadeh Esfahani; Mansooreh Shekarchizadeh Esfahani
Journal:  Eur J Transl Myol       Date:  2018-03-06

3.  Modified Tong Xie Yao Fang relieves solitary rectal ulcer syndrome: A case report.

Authors:  Li-Li Zhang; Wan-Shan Hao; Meng Xu; Chang Li; Yuan-Yuan Shi
Journal:  World J Clin Cases       Date:  2019-08-06       Impact factor: 1.337

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.